Pre-treatment serum phosphate as a metabolic correlate of live birth after IVF/ICSI: a retrospective cohort study

Vollständiger Abstract

Worum geht es in dieser Arbeit?

Background Oocyte developmental competence is influenced by the systemic metabolic milieu during folliculogenesis. Inorganic phosphate is essential for ATP synthesis, nucleic acid metabolism, and phosphorylation-dependent signalling, but its relationship with assisted reproductive technology outcomes remains unclear. We investigated whether pre-treatment fasting serum phosphate was associated with live birth after first IVF/ICSI fresh embryo transfer. Methods This retrospective cohort study included 2, 226 women aged 20–42 years undergoing their first IVF/ICSI cycle with fresh embryo transfer between January 2022 and June 2024. Serum phosphate was measured before ovarian stimulation and analysed as quartiles and per 1-SD increase (0.146 mmol/L). Multivariable logistic regression assessed associations with live birth, adjusting for demographic, ovarian reserve, metabolic, and treatment-related factors. Restricted cubic splines evaluated dose–response relationships. Measurement-window analyses stratified participants by the interval between biochemistry assessment and oocyte retrieval. Results The overall live birth rate was 60%, increasing from 56% in the lowest phosphate quartile to 66% in the highest (P for trend = 0.003). Each 1-SD increase in serum phosphate was associated with higher odds of live birth (adjusted OR 1.15, 95% CI 1.06–1.26; P = 0.002), with a linear dose–response (P for non-linearity = 0.305). Serum phosphate was not associated with MII oocyte count or usable embryo count. In measurement-window analyses, the association was consistent in the 60–120 day window (n = 1, 485; adjusted OR 1.18, 95% CI 1.03–1.35) and the 120–180 day window (n = 637; adjusted OR 1.16, 95% CI 1.01–1.34). The 0–60 day stratum was underpowered (n = 104). Additional adjustment for calcium, alkaline phosphatase, fasting glucose, and trigger-day progesterone did not materially alter the results. Conclusions Higher pre-treatment serum phosphate was associated with higher odds of live birth after IVF/ICSI, independent of oocyte yield. External validation and mechanistic studies are required before clinical application.